590 related articles for article (PubMed ID: 34064197)
1. The Interplay between the Immune and the Endocannabinoid Systems in Cancer.
Braile M; Marcella S; Marone G; Galdiero MR; Varricchi G; Loffredo S
Cells; 2021 May; 10(6):. PubMed ID: 34064197
[TBL] [Abstract][Full Text] [Related]
2. Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from
Nigro E; Formato M; Crescente G; Daniele A
Molecules; 2021 May; 26(9):. PubMed ID: 34063214
[No Abstract] [Full Text] [Related]
3. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
4. Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.
De Petrocellis L; Di Marzo V
J Neuroimmune Pharmacol; 2010 Mar; 5(1):103-21. PubMed ID: 19847654
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoids and the Immune System in Health and Disease.
Cabral GA; Ferreira GA; Jamerson MJ
Handb Exp Pharmacol; 2015; 231():185-211. PubMed ID: 26408161
[TBL] [Abstract][Full Text] [Related]
7. LPS-mediated neutrophil VEGF-A release is modulated by cannabinoid receptor activation.
Braile M; Cristinziano L; Marcella S; Varricchi G; Marone G; Modestino L; Ferrara AL; De Ciuceis A; Scala S; Galdiero MR; Loffredo S
J Leukoc Biol; 2021 Mar; 109(3):621-631. PubMed ID: 32573828
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the CB
Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
[TBL] [Abstract][Full Text] [Related]
9. The Immune Endocannabinoid System of the Tumor Microenvironment.
Kienzl M; Kargl J; Schicho R
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255584
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid receptors and endocannabinoids: evidence for new players.
Mackie K; Stella N
AAPS J; 2006 Apr; 8(2):E298-306. PubMed ID: 16796380
[TBL] [Abstract][Full Text] [Related]
11. Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB
Navarro G; Borroto-Escuela D; Angelats E; Etayo Í; Reyes-Resina I; Pulido-Salgado M; Rodríguez-Pérez AI; Canela EI; Saura J; Lanciego JL; Labandeira-García JL; Saura CA; Fuxe K; Franco R
Brain Behav Immun; 2018 Jan; 67():139-151. PubMed ID: 28843453
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological actions of cannabinoids.
Pertwee RG
Handb Exp Pharmacol; 2005; (168):1-51. PubMed ID: 16596770
[TBL] [Abstract][Full Text] [Related]
13. The pharmacology of cannabinoid receptors and their ligands: an overview.
Pertwee RG
Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099
[TBL] [Abstract][Full Text] [Related]
14. What we know and do not know about the cannabinoid receptor 2 (CB2).
Malfitano AM; Basu S; Maresz K; Bifulco M; Dittel BN
Semin Immunol; 2014 Oct; 26(5):369-79. PubMed ID: 24877594
[TBL] [Abstract][Full Text] [Related]
15. Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function.
Cabral GA; Rogers TJ; Lichtman AH
J Neuroimmune Pharmacol; 2015 Jun; 10(2):193-203. PubMed ID: 26054900
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.
Ashton JC; Wright JL; McPartland JM; Tyndall JD
Curr Med Chem; 2008; 15(14):1428-43. PubMed ID: 18537620
[TBL] [Abstract][Full Text] [Related]
17. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
Qamri Z; Preet A; Nasser MW; Bass CE; Leone G; Barsky SH; Ganju RK
Mol Cancer Ther; 2009 Nov; 8(11):3117-29. PubMed ID: 19887554
[TBL] [Abstract][Full Text] [Related]
18. Crystal Structure of the Human Cannabinoid Receptor CB2.
Li X; Hua T; Vemuri K; Ho JH; Wu Y; Wu L; Popov P; Benchama O; Zvonok N; Locke K; Qu L; Han GW; Iyer MR; Cinar R; Coffey NJ; Wang J; Wu M; Katritch V; Zhao S; Kunos G; Bohn LM; Makriyannis A; Stevens RC; Liu ZJ
Cell; 2019 Jan; 176(3):459-467.e13. PubMed ID: 30639103
[TBL] [Abstract][Full Text] [Related]
19. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
Pertwee RG
Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
[TBL] [Abstract][Full Text] [Related]
20. The endocannabinoid receptors CB1 and CB2 affect the regenerative potential of adipose tissue MSCs.
Ruhl T; Karthaus N; Kim BS; Beier JP
Exp Cell Res; 2020 Apr; 389(1):111881. PubMed ID: 32006556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]